Cited by 475Inflammatory Bowel DiseaseGut microbiota and healthMicroscopic Colitis

Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis

Open access
Colman, Ruben J., Rubin, David T.·2014·Journal of Crohn's and Colitis

Abstract

Background and aims: Fecal microbiota transplantation (FMT) has gained interest as a novel treatment option for inflammatory bowel diseases (IBD). While publications describing FMT as therapy for IBD have more than doubled since 2012, research that investigates FMT treatment efficacy has been scarce. We conducted a systematic review and meta-analysis to evaluate the efficacy of FMT as treatment for patients with IBD. Methods: A systematic literature search was performed through May 2014. Inclusion criteria required FMT as the primary therapeutic agent. Clinical remission (CR) and/or mucosal healing were defined as primary outcomes. Studies were excluded if they did not report clinical outcomes or included patients with infections. Results: Eighteen studies (9 cohort studies, 8 case studies and 1 randomized controlled trial) were included. 122 patients were described (79 ulcerative colitis (UC); 39 Crohn's disease (CD); 4 IBD unclassified). Overall, 45% (54/119) of patients achieved CR during follow-up. Among the cohort studies, the pooled proportion of patients that achieved CR was 36.2% (95% CI 17.4%–60.4%), with a moderate risk of heterogeneity (Cochran's Q, P = 0.011; I2 = 37%). Subgroup analyses demonstrated a pooled estimate of clinical remission of 22% (95% CI 10.4%–40.8%) for UC (P = 0.37; I2 = 0%) and 60.5% (95% CI 28.4%–85.6%) for CD (P = 0.05; I2 = 37%). Six studies performed microbiota analysis. Conclusions: This analysis suggests that FMT is a safe, but variably efficacious treatment for IBD. More randomized controlled trials are needed and should investigate frequency of FMT administration, donor selection and standardization of microbiome analysis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.crohns.2014.08.006

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [5]Borody TJ Leis S McGrath K Treatment of chronic constipation and colitis using human probiotic infusions 2001 Probiotics, Prebiotics and New Foods Conference Universita Urbaniana, Rome 2–4 September 2001
  2. [19]Wang M Wang H Zhang F Standard fecal microbiota transplantation through mid-gut is effective therapy for refractory ulcerative colitis. Journal of Gastroenterology and Hepatology 2013 28 590
  3. [28]Zhang F- M Wang H- G Wang M Cui B-T Huang G Ji G-Z Fan Z-N Standard fecal microbiota transplantation through mid-gut is an effective therapy of refractory Crohn's disease. J Gastroenterol Hepatol 2013 28 9 25168749

Cited by

Sorted by citations

Authors
Colman, R. J., & Rubin, D. T.
Affiliations
University of Chicago (US)
Corresponding author
Rubin, David T.
Venue
Journal of Crohn's and Colitis
Published
2014-12-01
Volume
8
Issue
12
Pages
1569-1581
ISSN
  • 1873-9946 (ISSN-L)
  • 1876-4479
OpenAlex
W2056515449
Cited by
475
References
55
Citations by year
2026: 7 · 2025: 29 · 2024: 26 · 2023: 30 · 2022: 40 · 2021: 35 · 2020: 36 · 2019: 40 · 2018: 53 · 2017: 72 · 2016: 65 · 2015: 38 · 2014: 3
FWCI
7.86
Type
journal article
Language
en
Open access
Locations
  • Journal of Crohn s and Colitis (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, other-oa)
  • PubMed Central (acceptedVersion)
Funders
Digestive Diseases Research Core Center (DDRCC) (NIDDK P30DK42086)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Epidemiology › Microscopic Colitis
Keywords
fecal microbiota transplantation, inflammatory bowel disease
MeSH terms
Feces, Humans, Intestinal Mucosa, Remission Induction, Transplantation, Inflammatory Bowel Diseases, Gastrointestinal Tract, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review